Gut microbiota’s role in leukemia treatment responses is explored, with evidence suggesting diet and prebiotics may help manage microbiota alterations in patients. Diet during pregnancy, breastfeeding, and gut microbiota composition all intersect, potentially influencing leukemia risks and treatment outcomes.
FDA sends letter to Novartis over ‘significant’ Kymriah manufacturing safety concerns
The FDA on Tuesday released a new untitled letter, sent in August to Novartis, after the agency’s inspectors found new and significant issues with how